299 related articles for article (PubMed ID: 32105011)
1. Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil.
Çakan M; Karadağ ŞG; Ayaz NA
Turk J Pediatr; 2019; 61(5):771-775. PubMed ID: 32105011
[TBL] [Abstract][Full Text] [Related]
2. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Leung AKC; Lam JM; Alobaida S; Leong KF; Wong AHC
Curr Pediatr Rev; 2021; 17(4):273-287. PubMed ID: 33902423
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis.
Tayfur AC; Topaloglu R; Gulhan B; Bilginer Y
Mod Rheumatol; 2015 Jul; 25(4):615-20. PubMed ID: 25800510
[TBL] [Abstract][Full Text] [Related]
4. Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin.
Shahani L
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22907859
[TBL] [Abstract][Full Text] [Related]
5. [A case of juvenile dermatomyositis with calcinosis universalis--remarkable improvement with aluminum hydroxide therapy].
Aihara Y; Mori M; Ibe M; Kuriyama T; Takahashi Y; Shimizu C; Shike H; Mitsuda T; Yokota S
Ryumachi; 1994 Oct; 34(5):879-84. PubMed ID: 7801200
[TBL] [Abstract][Full Text] [Related]
6. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
Vignesh P; Barman P; Basu S; Mondal S; Ishran B; Kumrah R; Dod A; Garg R; Rawat A; Singh S
Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969
[TBL] [Abstract][Full Text] [Related]
7. [Unrecognized juvenile dermatomyositis complicated by calcinosis universalis: a case report from Cameroon].
Mandengue CE; Nouedoui C; Atangana PJ
Med Sante Trop; 2013; 23(4):458-61. PubMed ID: 24401174
[TBL] [Abstract][Full Text] [Related]
8. Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis.
Lanis A; Volochayev R; Kleiner DE; Vittal A; Heller T; Rider LG; Shenoi S
Pediatr Rheumatol Online J; 2022 Apr; 20(1):30. PubMed ID: 35443665
[TBL] [Abstract][Full Text] [Related]
9. Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate.
Slimani S; Abdessemed A; Haddouche A; Ladjouze-Rezig A
Joint Bone Spine; 2010 Jan; 77(1):70-2. PubMed ID: 20031471
[TBL] [Abstract][Full Text] [Related]
10. Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash.
Huber AM; Kim S; Reed AM; Carrasco R; Feldman BM; Hong SD; Kahn P; Rahimi H; Robinson AB; Vehe RK; Weiss JE; Spencer C;
J Rheumatol; 2017 Jan; 44(1):110-116. PubMed ID: 27803135
[TBL] [Abstract][Full Text] [Related]
11. The clinical features of juvenile dermatomyositis: A single-centre inception cohort.
Cancarini P; Nozawa T; Whitney K; Bell-Peter A; Marcuz JA; Taddio A; Guo J; Dover S; Feldman BM
Semin Arthritis Rheum; 2022 Dec; 57():152104. PubMed ID: 36183479
[TBL] [Abstract][Full Text] [Related]
12. Calcinosis cutis presenting years before other clinical manifestations of juvenile dermatomyositis: report of two cases.
Wananukul S; Pongprasit P; Wattanakrai P
Australas J Dermatol; 1997 Nov; 38(4):202-5. PubMed ID: 9431716
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis.
Marco Puche A; Calvo Penades I; Lopez Montesinos B
Clin Exp Rheumatol; 2010; 28(1):135-40. PubMed ID: 20346254
[TBL] [Abstract][Full Text] [Related]
14. Recovery of Severe Muscular and Fascial Calcinosis After Treatment With Bisphosphonates in a Child With Juvenile Dermatomyositis.
Cañas CA; Bonilla-Abadía F; Mejía M; Tobón GJ
J Clin Rheumatol; 2015 Aug; 21(5):267-9. PubMed ID: 26203832
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia during the resolution of calcinosis universalis in juvenile dermatomyositis.
Ostrov BE; Goldsmith DP; Eichenfield AH; Athreya BH
J Rheumatol; 1991 Nov; 18(11):1730-4. PubMed ID: 1787495
[TBL] [Abstract][Full Text] [Related]
16. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis.
Wang A; Morgan GA; Paller AS; Pachman LM
J Am Acad Dermatol; 2021 Jun; 84(6):1610-1618. PubMed ID: 33359787
[TBL] [Abstract][Full Text] [Related]
17. Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.
Martillotti J; Moote D; Zemel L
Pediatr Radiol; 2014 Jan; 44(1):115-8. PubMed ID: 23839717
[TBL] [Abstract][Full Text] [Related]
18. Juvenile dermatomyositis: a tertiary center experience.
Barut K; Aydin PO; Adrovic A; Sahin S; Kasapcopur O
Clin Rheumatol; 2017 Feb; 36(2):361-366. PubMed ID: 28058540
[TBL] [Abstract][Full Text] [Related]
19. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis.
Fisler RE; Liang MG; Fuhlbrigge RC; Yalcindag A; Sundel RP
J Am Acad Dermatol; 2002 Oct; 47(4):505-11. PubMed ID: 12271292
[TBL] [Abstract][Full Text] [Related]
20. Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial.
Shiari R; Khalili M; Zeinali V; Shashaani N; Samami M; Moghaddamemami FH
Pediatr Rheumatol Online J; 2024 Jan; 22(1):2. PubMed ID: 38166943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
